Nimer, 2,148 patient vitamin A prophylaxis study: 21% lower hospitalization [p=0.4] and 21% lower severe cases [p=0.36] https://c19p.org/nimera
copied to clipboard
The impact of vitamin and mineral supplements usage prior to COVID-19 infection on disease severity and hospitalization
et al., Bosnian Journal of Basic Medical Sciences, doi:10.17305/bjbms.2021.7009
Retrospective survey based analysis of 2,148 COVID-19 recovered patients in Jordan, showing no significant differences in the risk of severity and hospitalization with vitamin A prophylaxis.
|
risk of hospitalization, 21.2% lower, RR 0.79, p = 0.40, treatment 15 of 144 (10.4%), control 204 of 2,004 (10.2%), adjusted per study, odds ratio converted to relative risk, multivariable.
|
|
risk of severe case, 20.8% lower, RR 0.79, p = 0.36, treatment 17 of 144 (11.8%), control 243 of 2,004 (12.1%), adjusted per study, odds ratio converted to relative risk, multivariable.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Nimer et al., 28 Feb 2022, retrospective, Jordan, peer-reviewed, survey, 4 authors, study period March 2021 - July 2021.
Contact:
rmnimer@just.edu.jo.
nimer
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.